Multiparameter flow cytometry is a highly sensitive, fast, and specific diagnostic technology with a wide range of applicability in hematology. Although well-established eight-color immunophenotyping panels are already available, most Brazilian clinical laboratories are equipped with four-color flow cytometer facilities. Based on this fact, the Brazilian Group of Flow Cytometry (Grupo Brasileiro de Citometria de Fluxo, GBCFLUX) for standardization of clinical flow cytometry has proposed an antibody panel designed to allow precise diagnosis and characterization of acute leukemia (AL) within resource-restricted areas. Morphological analysis of bone marrow smears, together with the screening panel, is mandatory for the primary identification o...
Introduction: Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia where the bla...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
ABSTRACT Minimal residual disease is the most powerful predictor of outcome in acute leukemia and is...
Introduction: Flow cytometry has become an increasingly important tool in the clinical laboratory fo...
On behalf of GBCFLUX.[Background]: Multiparametric flow cytometry (MFC) is a powerful tool for the d...
BACKGROUND AND OBJECTIVES: Flow cytometry is nowadays the preferred method for immunophenotypic id...
Introduction: Immunophenotyping by Flow Cytometry (FC) is an essential method for diagnosis and clas...
Introduction: Multiparametric flow cytometry immunophenotype (MFCI) plays a crucial role in the diag...
Background: Leukemias are abnormal proliferation of hematopoietic cells, causing progressive infiltr...
AbstractMinimal residual disease is the most powerful predictor of outcome in acute leukemia and is ...
Flow cytometry immunophenotyping of bone marrow tumor blasts is one of the principal methods used fo...
EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708): et al.This work is licensed under a Creative Comm...
Objective: Acute leukemia (AL) is a broad, heterogeneous group of malignant diseases. The diagnostic...
Introduction: The minimal residual disease (MRD) status plays a crucial role in the treatment of acu...
The precision of immunological characterization of leukemias was improved by a certain number of tec...
Introduction: Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia where the bla...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
ABSTRACT Minimal residual disease is the most powerful predictor of outcome in acute leukemia and is...
Introduction: Flow cytometry has become an increasingly important tool in the clinical laboratory fo...
On behalf of GBCFLUX.[Background]: Multiparametric flow cytometry (MFC) is a powerful tool for the d...
BACKGROUND AND OBJECTIVES: Flow cytometry is nowadays the preferred method for immunophenotypic id...
Introduction: Immunophenotyping by Flow Cytometry (FC) is an essential method for diagnosis and clas...
Introduction: Multiparametric flow cytometry immunophenotype (MFCI) plays a crucial role in the diag...
Background: Leukemias are abnormal proliferation of hematopoietic cells, causing progressive infiltr...
AbstractMinimal residual disease is the most powerful predictor of outcome in acute leukemia and is ...
Flow cytometry immunophenotyping of bone marrow tumor blasts is one of the principal methods used fo...
EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708): et al.This work is licensed under a Creative Comm...
Objective: Acute leukemia (AL) is a broad, heterogeneous group of malignant diseases. The diagnostic...
Introduction: The minimal residual disease (MRD) status plays a crucial role in the treatment of acu...
The precision of immunological characterization of leukemias was improved by a certain number of tec...
Introduction: Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia where the bla...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
ABSTRACT Minimal residual disease is the most powerful predictor of outcome in acute leukemia and is...